| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |